Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma

J. VodiČka, J. Fichtl, J. Šebek, K. ProchÁzkovÁ, M. SkÁla, V. TŘeŠka, S. Kormunda, B. VaŇkovÁ, M. SvatoŇ, O. TopolČan, R. KuČera,

. 2020 ; 40 (12) : 7045-7051. [pub] -

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027588

BACKGROUND/AIM: The lungs are the second most common site of cancer dissemination. The aim of this study was to analyze a cohort of patients operated for pulmonary metastases from colorectal carcinoma over a period of 18 years. PATIENTS AND METHODS: In a group of 104 patients, relations were sought between overall survival or disease-free survival and preoperative levels of selected biomarkers, number of metastases and the condition of the intrathoracic lymphatic nodes. Median observation period was 63 months. RESULTS: The 5-year survival rate was 54.3%. Risk of disease progression and risk of death increases in case of occurrence of 2 or more metastases, affection of intrathoracic lymph nodes and levels of CA 19-9, TPS or CEA above cut-off value. CONCLUSION: Prognostic factors that determine overall survival as well as disease-free survival are the number of metastases, the condition of intrathoracic lymphatic nodes and the preoperative levels of biomarkers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027588
003      
CZ-PrNML
005      
20210405094750.0
007      
ta
008      
210105s2020 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/anticanres.14731 $2 doi
035    __
$a (PubMed)33288601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Vodička, Josef $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
245    10
$a Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma / $c J. VodiČka, J. Fichtl, J. Šebek, K. ProchÁzkovÁ, M. SkÁla, V. TŘeŠka, S. Kormunda, B. VaŇkovÁ, M. SvatoŇ, O. TopolČan, R. KuČera,
520    9_
$a BACKGROUND/AIM: The lungs are the second most common site of cancer dissemination. The aim of this study was to analyze a cohort of patients operated for pulmonary metastases from colorectal carcinoma over a period of 18 years. PATIENTS AND METHODS: In a group of 104 patients, relations were sought between overall survival or disease-free survival and preoperative levels of selected biomarkers, number of metastases and the condition of the intrathoracic lymphatic nodes. Median observation period was 63 months. RESULTS: The 5-year survival rate was 54.3%. Risk of disease progression and risk of death increases in case of occurrence of 2 or more metastases, affection of intrathoracic lymph nodes and levels of CA 19-9, TPS or CEA above cut-off value. CONCLUSION: Prognostic factors that determine overall survival as well as disease-free survival are the number of metastases, the condition of intrathoracic lymphatic nodes and the preoperative levels of biomarkers.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a kolorektální nádory $x komplikace $x patologie $7 D015179
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x sekundární $x chirurgie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a metastázy nádorů $7 D009362
650    _2
$a prognóza $7 D011379
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fichtl, Jakub $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Šebek, Jakub $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Procházková, Kristýna $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Skála, Martin $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Třeška, Vladislav $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Kormunda, Stanislav $u Department of Surgery, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Vaňková, Bohuslava $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic. $7 xx0258705
700    1_
$a Svatoń, Martin $u Department of Pneumology and Phtisiology, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Topolčan, Ondřej $u Department of Immunochemistry Diagnostics, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Kučera, Radek $u Department of Immunochemistry Diagnostics, Charles University, Faculty of Medicine in Pilsen, University Hospital Pilsen, Pilsen, Czech Republic kucerar@fnplzen.cz.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 40, č. 12 (2020), s. 7045-7051
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33288601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210405094701 $b ABA008
999    __
$a ok $b bmc $g 1607923 $s 1118768
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 40 $c 12 $d 7045-7051 $e - $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace